NCT05207189View on ClinicalTrials.gov

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Female Stress IncontinenceStress Urinary Incontinence
Interventions
BIOLOGICAL

UVT

Chemically-treated, viro-inactivated, freeze-dried and irradiated umbilical vein allograft placed in replacement of a failed synthetic sling during a surgical act performed by the investigator.

Trial Locations (3)

44000

Hôtel-Dieu, CHU de Nantes, Nantes

69310

Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite

75013

Hôpital de la Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris

Sponsors
All Listed Sponsors
lead

TBF Genie Tissulaire

INDUSTRY

NCT05207189 - Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications | Biotech Hunter | Biotech Hunter